Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-Boc-4-(3-oxo-3-phenylpropyl)piperidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

301232-43-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 301232-43-9 Structure
  • Basic information

    1. Product Name: 1-Boc-4-(3-oxo-3-phenylpropyl)piperidine
    2. Synonyms: 1-Boc-4-(3-oxo-3-phenylpropyl)piperidine;tert-butyl 4-(3-oxo-3-phenylpropyl)piperidine-1-carboxylate
    3. CAS NO:301232-43-9
    4. Molecular Formula: C19H27NO3
    5. Molecular Weight: 317.42258
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 301232-43-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 428.5°C at 760 mmHg
    3. Flash Point: 212.9°C
    4. Appearance: /
    5. Density: 1.064g/cm3
    6. Vapor Pressure: 1.51E-07mmHg at 25°C
    7. Refractive Index: 1.518
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 1-Boc-4-(3-oxo-3-phenylpropyl)piperidine(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1-Boc-4-(3-oxo-3-phenylpropyl)piperidine(301232-43-9)
    12. EPA Substance Registry System: 1-Boc-4-(3-oxo-3-phenylpropyl)piperidine(301232-43-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 301232-43-9(Hazardous Substances Data)

301232-43-9 Usage

Chemical structure

Piperidine derivative with a tert-butoxycarbonyl (Boc) protecting group at the N-1 position and a 3-oxo-3-phenylpropyl substituent at the 4-position.

Functional groups

a. Boc protecting group
b. Piperidine ring
c. 3-oxo-3-phenylpropyl substituent

Applications

a. Building block in organic synthesis
b. Preparation of pharmaceuticals and biologically active compounds

Pharmacological properties

a. Potential analgesic effects
b. Potential anesthetic effects

Research areas

a. Ligand in the synthesis of metal complexes for catalysis
b. Other applications in medicinal chemistry and related fields

Check Digit Verification of cas no

The CAS Registry Mumber 301232-43-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,2,3 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 301232-43:
(8*3)+(7*0)+(6*1)+(5*2)+(4*3)+(3*2)+(2*4)+(1*3)=69
69 % 10 = 9
So 301232-43-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H27NO3/c1-19(2,3)23-18(22)20-13-11-15(12-14-20)9-10-17(21)16-7-5-4-6-8-16/h4-8,15H,9-14H2,1-3H3

301232-43-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-(3-oxo-3-phenylpropyl)piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:301232-43-9 SDS

301232-43-9Relevant articles and documents

Ni-Catalyzed β-Alkylation of Cyclopropanol-Derived Homoenolates

Mills, L. Reginald,Zhou, Cuihan,Fung, Emily,Rousseaux, Sophie A. L.

, p. 8805 - 8809 (2019/11/03)

Metal homoenolates are valuable synthetic intermediates which provide access to β-functionalized ketones. In this report, we disclose a Ni-catalyzed β-alkylation reaction of cyclopropanol-derived homoenolates using redox-active N-hydroxyphthalimide (NHPI) esters as the alkylating reagents. The reaction is compatible with 1°, 2°, and 3° NHPI esters. Mechanistic studies imply radical activation of the NHPI ester and 2e β-carbon elimination occurring on the cyclopropanol.

Iron-Catalysed Remote C(sp3)?H Azidation of O-Acyl Oximes and N-Acyloxy Imidates Enabled by 1,5-Hydrogen Atom Transfer of Iminyl and Imidate Radicals: Synthesis of γ-Azido Ketones and β-Azido Alcohols

Torres-Ochoa, Rubén O.,Leclair, Alexandre,Wang, Qian,Zhu, Jieping

supporting information, p. 9477 - 9484 (2019/05/21)

In the presence of a catalytic amount of iron(III) acetylacetonate [Fe(acac)3], the reaction of structurally diverse ketoxime esters with trimethylsilyl azide (TMSN3) afforded γ-azido ketones in good to excellent yields. This unprecedented distal γ-C(sp3)?H bond azidation reaction went through a sequence of reductive generation of an iminyl radical, 1,5-hydrogen atom transfer (1,5-HAT) and iron-mediated redox azido transfer to the translocated carbon radical. TMSN3 served not only as a nitrogen source to functionalise the unactivated C(sp3)?H bond, but also as a reductant to generate the catalytically active FeII species in situ. Based on the same principle, a novel β-C(sp3)?H functionalisation of alcohols via N-acyloxy imidates was subsequently realised, leading, after hydrolysis of the resulting ester, to β-azido alcohols, which are important building blocks in organic and medicinal chemistry.

Quinoline derivatives as neurokinin receptor antagonists

-

Page/Page column 33, (2009/04/24)

The present invention relates to substituted quinoline hydrazides of Formula (I): wherein R1, R2, R3, R4, R5, X, Y and Z are defined herein, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors. These compounds can thus be used in methods of treatment to suppress and treat such disorders.

QUINOLINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS

-

Page/Page column 17, (2008/06/13)

The present invention relates to substituted quinoline derivatives of Formula (I); wherein hal, n, A, formula (a) , R1, R2, R3, R4, R5 and R6 are defined herein, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors. These compounds can thus be used in methods of treatment to suppress and treat such disorders.

N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II

Elliott, Jason M.,Carling, Robert W.,Chicchi, Gary G.,Crawforth, James,Hutson, Peter H.,Jones, A. Brian,Kelly, Sarah,Marwood, Rose,Meneses-Lorente, Georgina,Mezzogori, Elena,Murray, Fraser,Rigby, Michael,Royo, Inmaculada,Russell, Michael G.N.,Shaw, Duncan,Sohal, Bindi,Tsao, Kwei Lan,Williams, Brian

, p. 5752 - 5756 (2007/10/03)

Introduction of selected amine containing side chains into the 3-position of N′,2-diphenylquinoline-4-carbohydrazide based NK3 antagonists abolishes unwanted hPXR activation. Introduction of a fluorine at the 8-position is necessary to minimize unwanted hIKr affinity and a piperazine N-tert-butyl group is necessary for metabolic stability. The lead compound (8m) occupies receptors within the CNS following oral dosing (Occ90 7 mg/kg po; plasma Occ90 0.4 μM) and has good selectivity and excellent PK properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 301232-43-9